What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion

Clinical management of breakthrough cancer pain (BTcP) is still not satisfactory despite the availability of effective pharmacological agents. This is in part linked to the lack of clarity regarding certain essential aspects of BTcP, including terminology, definition, epidemiology and assessment. Ot...

Descripción completa

Detalles Bibliográficos
Autores principales: Vellucci, R., Fanelli, G., Pannuti, R., Peruselli, C., Adamo, S., Alongi, G., Amato, F., Consoletti, L., Lamarca, L., Liguori, S., Lo Presti, C., Maione, A., Mameli, S., Marinangeli, F., Marulli, S., Minotti, V., Miotti, D., Montanari, L., Moruzzi, G., Palermo, S., Parolini, M., Poli, P., Tirelli, W., Valle, A., Romualdi, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Therapy in Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757619/
https://www.ncbi.nlm.nih.gov/pubmed/26755179
http://dx.doi.org/10.1007/s40265-015-0519-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757619/
https://www.ncbi.nlm.nih.gov/pubmed/26755179
http://dx.doi.org/10.1007/s40265-015-0519-2

Ejemplares similares